Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses

BACKGROUND: A considerable proportion of patients suffering from schizophrenia show suboptimal responses to oral antipsychotics due to inadequate adherence. Hence, they are likely to benefit from switching to a long-acting injectable formulation. These post hoc analyses assessed the clinical effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciudad, Antonio, Anand, Ernie, Berggren, Lovisa, Casillas, Marta, Schacht, Alexander, Perrin, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825698/
https://www.ncbi.nlm.nih.gov/pubmed/24235837
http://dx.doi.org/10.2147/NDT.S50635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825698/
https://www.ncbi.nlm.nih.gov/pubmed/24235837
http://dx.doi.org/10.2147/NDT.S50635

Ejemplares similares